logo-loader

Faron Pharmaceuticals Ltd

Market:
AIM
Market Cap:
£138.53 m
Price
320.00 GBX
Change
13.27%
52 weeks high
375.00
52 weeks low
54.49

In brief

Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline focusing on acute organ traumas, vascular damage and cancer immunotherapy.